Patent · US Active

Antagonists of IL17C for the treatment of inflammatory disorders

US10815297B2 · kind B2 · utility

0Cited by

0References

8Claims

0Family size

Assignees

MORPHOSYS AG · DE
Galapagos NV · BE

Inventors

Andreas Bültmann · Planegg, DE
Robert Mühlbacher · Gräfelfing, DE
Teresa Garcia · Romainville, FR
Reginald Christophe Xavier Brys · Mechelen, BE
Luc Nelles · Mechelen, BE
Katja Conrath · Mechelen, BE

Key dates

Filing date	Nov 8, 2018
Grant date	Oct 27, 2020
Priority date	—
Expiry date	Dec 21, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides antagonists of IL17C for use in the treatment of an inflammatory disorder.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.